Modern opportunities of therapeutic treatment of allergic conjunctivitis. A review
<p>H1‑receptor antagonists are drugs of choice to treat allergy. They work very fast as their therapeutic effect develops within 10‑15 min, have good tolerability and almost no adverse side-effects, and require no frequent instillations. Levocabastine quickly inhibits allergic reaction caused...
Main Author: | D. Yu. Maychuk |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ophthalmology Publishing Group
2014-07-01
|
Series: | Oftalʹmologiâ |
Subjects: | |
Online Access: | http://www.ophthalmojournal.com/index.php/opht/article/view/20 |
Similar Items
-
The Early Efficacy of Topical Levocabastine in Patients with Allergic Conjunctivitis
by: Hiroshi Fujishima, et al.
Published: (2006-01-01) -
A contemporary look at allergic conjunctivitis
by: Pascale Dupuis, et al.
Published: (2020-01-01) -
Validation of the DECA criteria for allergic conjunctivitis severity and control
by: M. Cesárea Sánchez-Hernández, et al.
Published: (2020-10-01) -
Analyze on the value of conjunctival impression cytology in the diagnosis of allergic conjunctivitis
by: Ni Yin, et al.
Published: (2022-05-01) -
Allergic Conjunctivitis
by: Muhammed Vally, et al.
Published: (2017-11-01)